AR T-Cell Therapy Market to surge from $4.8B (2024) to $36.8B by 2034 at 33% CAGR, led by Adaptimmune Therapeutics, Atara Biotherapeutics, and Autolus Therapeutics.
AR T-Cell Therapy Market is emerging as one of the most transformative segments within modern oncology and personalized medicine. Valued at approximately $4.8 billion in …